Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma

Human Gene Therapy

Volumn 11, Issue 10, 2000, Pages 1429-1438

  Herrlinger, U ^a,b   Jacobs, A ^a,c   Quinones, A ^d   Woiciechowsky, C ^a,e   Sena Esteves, M ^a   Rainov, N G ^a,d   Fraefel, C ^a,f   Breakefield, X O ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^e HUMBOLDT UNIVERSITY   (Germany)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERPES VACCINE; HEXADIMETHRINE BROMIDE; TRANSFORMING GROWTH FACTOR BETA; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; GENE TARGETING; GENE THERAPY; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA; HERPES SIMPLEX; IMMUNOSTIMULATION; MOUSE; NONHUMAN; RETROVIRUS; TRANSGENE; TUMOR CELL; VACCINATION; VIRUS REPLICATION;

ANIMALS; CANCER VACCINES; CELL LINE; CERCOPITHECUS AETHIOPS; CRICETINAE; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOMA; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HELPER VIRUSES; HERPESVIRUS 1, HUMAN; HEXADIMETHRINE; HUMANS; LAC OPERON; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; TIME FACTORS; TRANSDUCTION, GENETIC; TRANSGENES; TUMOR CELLS, CULTURED; VERO CELLS;

EID: 0034234839     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340050057503     Document Type: Article

References (41)

1. ABE, A., MIYANOHARA, A., and FRIEDMANN, T. (1998). Polybrene increases the efficiency of gene transfer by lipofection. Gene Ther. 5, 708-711.
2. AKBASAK, A., OLDFIELD, E.H., and SARIS, S.C. (1991). Expression and modulation of major histocompatibility antigens on murine primary brain tumor in vitro. J. Neurosurg. 75, 922-929.
3. ALEXANDER, I.E., RUSSELL, D.W., and MILLER, A.D. (1994). DNA-damaging agents greatly increase the transduction of nondividing cells by adeno-associated virus vectors. J. Virol. 68, 8282-8287.
4. ALEXANDER I.E., RUSSELL, D.W., SPENCE, A.M., and MILLER, A.D. (1996). Effects of gamma irradiation on the transduction of dividing and nondividing cells in brain and muscle of rats by adeno-associated virus vectors. Hum. Gene Ther. 7, 841-850.
5. ANDREADIS, S., and PALSSON, B.O. (1997). Coupled effects of Polybrene and calf serum on the efficiency of retroviral transduction and the stability of retroviral vectors. Hum. Gene Ther. 8, 285-291.
6. ANDREANSKY, S.S., HE, B., GILLESPIE, G.Y., SOROCEANU, L., MARKERT, J., CHOU J., ROIZMAN, B., and WHITLEY, R.J. (1996). The application of genetically engineered herpes simplex viruses to the treatment of experimental brain tumors. Proc. Natl. Acad. Sci. U.S.A. 93, 11313-11318.
7. ARCASOY, S.M., LATOCHE, J.D., GONDOR, M., PITT, B.R., and PILEWSKI, J.M. (1997). Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro. Gene Ther. 4, 32-38.
8. AUSMAN, J.I., SHAPIRO, W.R., and RALL, D.P. (1970). Studies on the chemotherapy of experimental brain tumors: development of an experimental model. Cancer Res. 30, 2394-2400.
9. BANCHEREAU, J., and STEINMAN, R.M. (1998). Dendritic cells and the control of immunity. Nature (London) 392, 245-252.
10. BERGOLD, P., CASACCIA-BONNEFIL, P., XIU-LIU, Z., and FEDEROFF, H.J. (1993). Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 6165-6169.
11. BRUBAKER, J.O., THOMPSON, C.M., MORRISON, L.A., KNIPE, D.M., SIBER, G.R., and FINBERG, R.W. (1996). Th1-associated immune responses to beta-galactosidase expressed by a replication-defective herpes simplex virus. J. Immunol. 157, 1598-1604.
12. CHIOCCA, E.A., CHOI, B.B., CAI, W.Z., DELUCA, N.A., SCHAFFER, P.A., DIFIGLIA, M., BREAKEFIELD, X.O., and MARTUZA, R.L. (1990). Transfer and expression of the lacZ gene in rat brain neurons mediated by herpes simplex virus mutants. New Biol. 2, 739-746.
13. CUNNINGHAM, C., and DAVISON, A.J. (1993). A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197, 116-124.
14. DILLOO, D., RILL, D., ENTWISLE, C., BOURSNELL, M., ZHONG, W., HODLEN, W., HOLLADAY, M., INGLIS, S., and BRENNER, M. (1997). A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells. Blood 89, 119-127.
15. DRANOFF, G., JAFFEE, E., LAZENBY, A., GOLUMBEK, P., LEVITSKY, H., BROSE, K., JACKSON, V., HAMADA, H., PARDOLL, D., and MULLIGAN, R.C. (1993). Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity. Proc. Natl. Acad. Sci. U.S.A. 90, 3539-3543.
16. FAHKRAI, H., DORIGO, O., SHAWLER, D.L., LIN, H., MERCOLA, D., BLACK, K.L., ROYSTON, I., and SOBOL, R.E. (1996). Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc. Natl. Acad. Sci. U.S.A. 93, 2909-2914.
17. FRAEFEL, C., SONG, S., LIM, F., LANG, P., YU, L., WANG, Y., WILD, P., and GELLER, A.I. (1996). Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol. 70, 7190-7197.
18. FRAEFEL, C., JACOBY, D.R., LAGE, C., HILDERBRAND, H., CHOU, J.Y., ALT, F.W., BREAKEFIELD, X.O., and MAJZOUB, J.A. (1997). Gene transfer into hepatocytes mediated by helper virus free HSV/AAV hybrid vectors. Mol. Med. 3, 813-825.
19. FRAEFEL, C., BREAKEFIELD, X.O., and JACOBY, D.R., (1998). HSV-1 amplicon. In Gene Therapy for Neurological Disorders and Brain Tumors. E.A. Chiocca, X.O. Breakefield, eds. (Humana Press, Totowa, NJ) pp. 63-82.
20. GELLER, A.I., and BREAKEFIELD, X.O. (1988). A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241, 1667-1669.
21. HERRLINGER, U., KRAMM, C.M., JOHNSTON, K.M., LOUIS, D.N., FINKELSTEIN, D., REZNIKOFF, G., DRANOFF, G., BREAKEFIELD, X.O., and YU, J.S. (1997). Vaccination for experimental gliomas using GM-CSF transduced glioma cells. Cancer Gene Ther. 4, 345-352.
22. HERRLINGER, U., KRAMM, C.M., ABOODY-GUTERMAN, K.S., SILVER, J.S., IKEDA, K., JOHNSTON, K.M., PECHAN, P.A., BARTH, R.F., FINKELSTEIN, D., CHIOCCA, E.A., LOUIS, D.N., and BREAKEFIELD, X.O. (1998). Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector. Gene Ther. 5, 809-819.
23. HERRLINGER, U., JACOBS, A., AGHI, M., SCHUBACK, D.E., and BREAKEFIELD, X.O. (2000). HSV-1 vectors for gene therapy of experimental CNS tumors. In Methods in Molecular Medicine: Gene Therapy Protocols. P. Robbins, ed. (Humana Press, Totowa, NJ) pp. 287-312
24. JAFFEE, E.M., THOMAS, M.C., HUANG, A.Y.C., HAUDA, K.M., LEVITSKY, H.I., and PARDOLL, D.M. (1996). Enhanced immune priming with spatial distribution of paracrine cytokine vaccines. J. Immunother. 19, 176-183.
25. JOHNSTON, K.M., JACOBY, D., PECHAN, P.A., FRAEFEL, C., BORGHESANI, P., SCHUBACK, D., DUNN, R.J., SMITH, F.I., and BREAKEFIELD, X.O. (1997). HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells. Hum. Gene Ther. 8, 359-370.
26. KLEIHUES P., BURGER, P.C., PLATE, K.H., OHGAKI, H., and CAVENEE, W.K. (1997). Glioblastoma. In Pathology and Genetics of Tumours of the Nervous System. P. Kleihues and W.K. Cavenee, eds. (International Agency for Research on Cancer, Lyon, France) pp. 16-24.
27. LICHTOR, T., CLICK, R.P., KIM, T.S., HAND, R., and COHEN, E.P. (1995). Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells. J. Neurosurg. 83, 1038-1044.
28. QIN, H.X., and CHATTERJEE, S.K. (1996a). Cancer gene therapy using tumor cells infected with recombinant vaccinia virus expressing GM-CSF. Hum. Gene Ther. 7, 1853-1860.
29. QIN, H.X., and CHATTERJEE, S.K. (1996b). Construction of recombinant vaccinia virus expressing GM-CSF and its use as tumor vaccine. Gene Ther. 3, 59-66.
30. SAEKI, Y., ICHIKAWA, T., SAEKI, A., CHIOCCA, E.A., TOBLER, K., ACKERMANN, M., BREAKEFIELD, X.O., and FRAEFEL, C. (1998). Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: Rescue of replication-competent virus progeny and packaging of amplicon vectors. Hum. Gene Ther. 10, 2787-2794.
31. SMITH, C.A., BATES, P., RIVERA-GONZALEZ, R., GU, B., and DELUCA, N.A. (1993). ICP4, the major transcriptional regulatory protein of herpes simplex virus forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67, 4676-4687.
32. STEVENS, C.W., ZENG, M., and CERNIGLIA, G.J. (1996). Ionizing radiation greatly improves gene transfer efficiency in mammalian cells. Hum. Gene Ther. 7, 1727-1734.
33. SUN, M., ZHANG, G.R., YANG, T., YU, L., and GELLER, A.I. (1999). Improved titers for helper virus-free herpes simplex virus type 1 plasmid vectors by optimization of the packaging protocol and addition of noninfectious herpes simplex virus-related particles (previral DNA replication enveloped particles) to the packaging procedure. Hum. Gene Ther. 10, 2005-2011.
34. TAPSCOTT, S.J., MILLER, A.D., OLSON, J.M., BERGER, M.S., GROUDINE, M., and SPENCE, A.M. (1994). Gene therapy of rat 9L gliosarcoma tumors by transduction with selectable genes does not require drug selection. Proc. Natl. Acad. Sci. U.S.A. 91, 8185-8189.
35. TODA, M., RABKIN, S.D., KOJIMA, H., and MARTUZA, R.L. (1999). Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity. Hum. Gene Ther. 10, 385-393.
36. TRIPATHY S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, J.M. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after infection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
37. TUNG, C., FEDEROFF, H.J., BROWNLEE, M., KARPOFF, H., WEIGEL, T., BRENNAN, M.F., and FONG, Y. (1996). Rapid production of interleukin-2-secreting tumor cells by herpes simplex virus-mediated gene transfer: Implications for autologous vaccine production. Hum. Gene Ther. 7, 2217-2224.
38. TURNER, D.L., SNYDER, E.Y., and CEPKO, C.L. (1990). Lineage-independent determination of cell type in the embryonic mouse retina. Neuron 4, 833-845.
39. WANG, S., and VOS, J.M. (1996). A hybrid herpesvirus infectious vector based on Epstein-Barr virus and herpes simplex virus type 1 for gene transfer into human cells in vitro and in vivo. J. Virol. 70, 8422-8430.
40. YU, J.S., BURWICK, J.A., DRANOFF, G., and BREAKEFIELD, X.O. (1997). Gene therapy for metastatic brain tumors by vaccination with granulocyte-m acrophage colony-stimulating factor-transduced tumor cells. Hum. Gene Ther. 8, 1065-1072.
41. ZENG M., CERNIGLIA, G.J., ECK, S.L., and STEVENS, C.W. (1997). High-efficiency stable transfer of adenovirus into mammalian cells using ionizing radiation. Hum. Gen. Ther. 8, 1025-1032.